PrEP

Policy Brief Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the […]

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Infographic People Living with HIV Who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets May 15, 2023 A new study from the California HIV/AIDS Policy Research Centers finds that less than 30% of safety net providers in the Ryan White HIV/AIDS Program in Southern California offered smoking cessation services, […]

Full Report Improving Access to Essential Prevention Services: The Opportunities and Challenges of Expanding the Role of California’s Pharmacists March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that […]

Infographic Senate Bill 159 Implementation: California Pharmacists’ Perspectives On Opportunities And Challenges March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists surveyed […]

Policy Brief Senate Bill 159 Implementation California Pharmacists’ Perspectives on Opportunities and Challenges March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists […]

Policy Brief The Use of HIV Over-the Counter (OTC) test in California from April to September 2013 January 3, 2023 Approval in mid-2012 of a consumer-controlled OTC HIV test by the Food and Drug Administration (FDA), which is responsible for drug and medical device approval for sales to the public, has made real the possibility […]

Full Report A Decade of PrEP: Overcoming Access Barriers in the U.S. Through Expanded Delivery December 22, 2022 A decade after the FDA approved PrEP for HIV prevention, PrEP is still not accessible to all Americans who might benefit from this HIV prevention strategy. In this policy brief, we describe opportunities for expanded PrEP access. […]

Infographic 2021 COVID-19 Organizational Health Survey June 13, 2022 In the fall of 2021, the California HIV/AIDS Policy Research Centers conducted an online survey to document the direct impact of COVID-19 on healthcare and social services providers working to address HIV, viral hepatitis and sexually transmitted infections (STIs). Survey respondents included 30 organizations that submitted […]

Infographic Potential Impact and Equitable Reach of Senate Bill 306 (SB 306), STD Coverage and Care Act May 10, 2022 In 2022, California became the first state to require healthcare plans to cover the costs of home test kits for sexually transmitted diseases (STD) including HIV. Home test kits are provided through a prescription or […]